Abvida-M 50mg/1000mg Eazy Glide Tablet

Abvida-M 50mg/1000mg Eazy Glide Tablet is a tablet-form medicine used for type 2 diabetes, blood sugar control, insulin resistance, PCOS. It works by reduces glucose production in liver and improves insulin sensitivity in muscles. Falling under the diabetes care category, it is commonly prescribed in India for blood sugar management and diabetes control. The combination in Abvida-M 50mg/1000mg Eazy Glide Tablet (Metformin (50mg) + Vildagliptin (1000mg)) is formulated so that the individual ingredients act on related targets, often providing broader symptom relief than any single ingredient alone. Combination products like Abvida-M 50mg/1000mg Eazy Glide Tablet are widely used in Indian clinical practice when patients need multiple complementary actions in a single dose. Abvida-M 50mg/1000mg Eazy Glide Tablet is manufactured and marketed in India by Abvida-M 50mg/1000mg Eazy Glide Tablet. Like every medicine sold in India, it is regulated by the Central Drugs Standard Control Organisation (CDSCO) and must meet the quality standards specified in the Indian Pharmacopoeia. Abvida-M 50mg/1000mg Eazy Glide Tablet is supplied in a pack of 15 tablets. The current verified price through GoDavaii is approximately ₹254.04, which may vary slightly between pharmacies and cities. As a tablet-form medicine, Abvida-M 50mg/1000mg Eazy Glide Tablet should be stored, handled and used following the form-specific guidance below. Abvida-M 50mg/1000mg Eazy Glide Tablet is a prescription medicine in India. A valid prescription from a qualified medical professional is required to purchase it, and the medicine should only be used under medical supervision so that the dose, duration and monitoring are appropriate for the specific condition being treated. Always use Abvida-M 50mg/1000mg Eazy Glide Tablet exactly as advised by a qualified medical professional. Do not exceed the recommended dose, do not extend the course beyond what is prescribed, and do not share the medicine with family members even if their symptoms appear similar.